Biogen Inc. (BIIB)
NASDAQ
Closed
Oct 9, 2026
Day's Range
219.2352 wk Range
138.00Overview - BIIB - Biogen Inc.
Key Statistics
Valuation
Enterprise Value
39.55B
P/E (Trailing)
‪39.05‬
P/E (Forward)
‪13.29‬
PEG Ratio
‪-0.46‬
Price / Sales (TTM)
‪3.23‬
Price / Book
‪1.72‬
EV / EBITDA
‪11.77‬
Profitability
Gross Margin
‪71.60%‬
Profit Margin
‪8.32%‬
Operating Margin
‪25.05%‬
Return on Assets
‪5.20%‬
Return on Equity
‪4.57%‬
Ownership
Shares Outstanding
147.70M
Float
147.21M
Short % of Shares Outstanding
‪4.38%‬
Held by Insiders
‪0.18%‬
Held by Institutions
‪99.50%‬
Price stats
Beta
‪0.17‬
50-Day Avg
‪215.29‬
200-Day Avg
‪195.19‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
35 analysts
Average price target
‪$ 235.57‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BIIB - Biogen Inc.
Peers - BIIB - Biogen Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NASDAQ.
- BIIBNASDAQBiogen Inc.32.48BMarket Cap+29.94%52-week change39.06P/E (Trailing)‪8.32%‬Profit Margin
- AZNNASDAQAstraZeneca PLC243.33BMarket Cap-8.97%52-week change23.59P/E (Trailing)‪17.02%‬Profit Margin
- AMGNNASDAQAmgen Inc.217.89BMarket Cap+27.02%52-week change25.05P/E (Trailing)‪22.95%‬Profit Margin
- GILDNASDAQGilead Sciences, Inc.179.47BMarket Cap+21.53%52-week change17.87P/E (Trailing)‪-10.63%‬Profit Margin
- SNYNASDAQSanofi ADR95.65BMarket Cap-24.52%52-week change21.01P/E (Trailing)‪8.09%‬Profit Margin
- ROPNASDAQRoper Technologies Inc.36.00BMarket Cap-39.80%52-week change15.21P/E (Trailing)‪30.24%‬Profit Margin
- GRFSNASDAQGrifols S.A. ADR4.97BMarket Cap-31.46%52-week change9.75P/E (Trailing)‪6.09%‬Profit Margin
Profile Summary - BIIB - Biogen Inc.
About
Biogen Inc. is a biotechnology company focused on discovering, developing, and delivering therapies for serious neurological, neurodegenerative, and rare diseases. Biogen’s current portfolio includes treatments for multiple sclerosis, Alzheimer’s disease, spinal muscular atrophy, amyotrophic lateral sclerosis, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
